PetVivo Holdings, Inc. is a biomedical device company that manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. Its lead product is Spryng, a veterinarian-administered intraarticular injection for managing lameness and other joint conditions, such as osteoarthritis, in dogs and horses. The company also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.